LAB · Standard BioTools Inc.
AI read · Bad for LAB
The AI's read
The claims could bring legal costs or slow the merger process. Standard BioTools says it believes its disclosures meet the law and denies the claims. It is adding information to try to avoid costs and delays, but says more claims may come and it cannot predict the outcome.